Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

<i>MET</i> amplification as a potential therapeutic target in gastric cancer

17 Nov 2012

Abstract excerpt

// Hisato Kawakami 1 , Isamu Okamoto 1 , Tokuzo Arao 2 , Wataru Okamoto 1 , Kazuko Matsumoto 2 , Hirokazu Taniguchi 4 , Kiyoko Kuwata 1 , Haruka Yamaguchi 1 , Kazuto Nishio 2 , Kazuhiko Nakagawa 1 , and Yasuhide Yamada 3 1 Department of Medical Oncology, Kinki University Faculty of Medicine, 377-2 Ohno-higashi, Osaka-Sayama, Osaka, Japan; 2 Department of Genome Biology, Kinki University Faculty of Medicine, 377-2...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cholangiocarcinoma and Gallbladder Cancer Studies
Share to Liver physiology and pathology
Share to Lung Cancer Treatments and Mutations

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 23327903
DOI: 10.18632/oncotarget.718

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 3 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

<i>MET</i> amplification as a potential therapeutic target in gastric cancerPMID 23327903Read ↗

Impact of MET amplification on gastric cancer: Possible roles as a novel prognostic marker and a potential therapeutic targetSemantic proximity Read ↗

MET amplification in metastatic colorectal cancer: an acquired response to EGFR inhibition, not a <i>de novo</i> phenomenonSemantic proximity Read ↗

Amplification of <i>MET</i> may identify a subset of cancers with extreme sensitivity to the selective tyrosine kinase inhibitor PHA-665752Semantic proximity Read ↗

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcomeSemantic proximity Read ↗

Gastric cancer patient with c-MET amplification treated with crizotinib after failed multi-line treatment: A case report and literature reviewSemantic proximity Read ↗

MET tyrosine kinase receptor expression and amplification as prognostic biomarkers of survival in gastroesophageal adenocarcinomaSemantic proximity Read ↗

MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.Semantic proximity Read ↗

MET-amplified gastric cancers exhibit co-amplifications of BRAF, CDK6, and EGFR.Semantic proximity Read ↗

Analysis of 1,115 patients tested for MET amplification and therapy response in the MD Anderson Phase I Clinic.Semantic proximity Read ↗

MET amplification identified by next-generation sequencing and its clinical relevance for MET inhibitorsSemantic proximity Read ↗

<i>TNK</i><i>2</i> gene amplification is a novel predictor of a poor prognosis in patients with gastric cancerSemantic proximity Read ↗

Clinical Implications of <i>MET</i> Gene Copy Number in Lung CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.